181 related articles for article (PubMed ID: 37875589)
1. Identification of ONECUT3 as a stemness-related transcription factor regulating NK cell-mediated immune evasion in pancreatic cancer.
Shi H; Tsang Y; Yang Y; Chin HL
Sci Rep; 2023 Oct; 13(1):18133. PubMed ID: 37875589
[TBL] [Abstract][Full Text] [Related]
2. Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer.
Chen PC; Ning Y; Li H; Su JG; Shen JB; Feng QC; Jiang SH; Shi PD; Guo RS
Cell Oncol (Dordr); 2024 Feb; 47(1):81-96. PubMed ID: 37606818
[TBL] [Abstract][Full Text] [Related]
3. Identification of CEACAM5 as a stemness-related inhibitory immune checkpoint in pancreatic cancer.
Shi H; Tsang Y; Yang Y
BMC Cancer; 2022 Dec; 22(1):1291. PubMed ID: 36494785
[TBL] [Abstract][Full Text] [Related]
4. Characterization of natural killer and cytotoxic T-cell immune infiltrates in pancreatic ductal adenocarcinoma.
Persky J; Cruz SM; Darrow MA; Judge SJ; Li Y; Bold RJ; Karnezis AN; Matsukuma KE; Qi L; Canter RJ
J Surg Oncol; 2024 Apr; 129(5):885-892. PubMed ID: 38196111
[TBL] [Abstract][Full Text] [Related]
5. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma.
Fitzgerald AA; Wang S; Agarwal V; Marcisak EF; Zuo A; Jablonski SA; Loth M; Fertig EJ; MacDougall J; Zhukovsky E; Trivedi S; Bhatia D; O'Neill V; Weiner LM
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34737215
[TBL] [Abstract][Full Text] [Related]
6. FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer.
Canel M; Sławińska AD; Lonergan DW; Kallor AA; Upstill-Goddard R; Davidson C; von Kriegsheim A; Biankin AV; Byron A; Alfaro J; Serrels A
Gut; 2023 Dec; 73(1):131-155. PubMed ID: 36977556
[TBL] [Abstract][Full Text] [Related]
7. Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells.
Yu Q; Newsome RC; Beveridge M; Hernandez MC; Gharaibeh RZ; Jobin C; Thomas RM
Gut Microbes; 2022; 14(1):2112881. PubMed ID: 35980869
[TBL] [Abstract][Full Text] [Related]
8. Perioperative, Spatiotemporally Coordinated Activation of T and NK Cells Prevents Recurrence of Pancreatic Cancer.
Brooks J; Fleischmann-Mundt B; Woller N; Niemann J; Ribback S; Peters K; Demir IE; Armbrecht N; Ceyhan GO; Manns MP; Wirth TC; Kubicka S; Bernhardt G; Smyth MJ; Calvisi DF; Gürlevik E; Kühnel F
Cancer Res; 2018 Jan; 78(2):475-488. PubMed ID: 29180478
[TBL] [Abstract][Full Text] [Related]
9. CD90 highly expressed population harbors a stemness signature and creates an immunosuppressive niche in pancreatic cancer.
Shi J; Lu P; Shen W; He R; Yang MW; Fang Y; Sun YW; Niu N; Xue J
Cancer Lett; 2019 Jul; 453():158-169. PubMed ID: 30954649
[TBL] [Abstract][Full Text] [Related]
10. Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma.
Ene-Obong A; Clear AJ; Watt J; Wang J; Fatah R; Riches JC; Marshall JF; Chin-Aleong J; Chelala C; Gribben JG; Ramsay AG; Kocher HM
Gastroenterology; 2013 Nov; 145(5):1121-32. PubMed ID: 23891972
[TBL] [Abstract][Full Text] [Related]
11. SALL4-related gene signature defines a specific stromal subset of pancreatic ductal adenocarcinoma with poor prognostic features.
Vienot A; Monnien F; Truntzer C; Mougey V; Bouard A; Pallandre JR; Molimard C; Loyon R; Asgarov K; Averous G; Ghiringhelli F; Bibeau F; Peixoto P; Borg C
Mol Oncol; 2023 Jul; 17(7):1356-1378. PubMed ID: 36587397
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of NK cell antitumor responses using an oncolytic parvovirus.
Bhat R; Dempe S; Dinsart C; Rommelaere J
Int J Cancer; 2011 Feb; 128(4):908-19. PubMed ID: 20473905
[TBL] [Abstract][Full Text] [Related]
13. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I.
Yamamoto K; Venida A; Yano J; Biancur DE; Kakiuchi M; Gupta S; Sohn ASW; Mukhopadhyay S; Lin EY; Parker SJ; Banh RS; Paulo JA; Wen KW; Debnath J; Kim GE; Mancias JD; Fearon DT; Perera RM; Kimmelman AC
Nature; 2020 May; 581(7806):100-105. PubMed ID: 32376951
[TBL] [Abstract][Full Text] [Related]
14. Genetic inactivation of Nupr1 acts as a dominant suppressor event in a two-hit model of pancreatic carcinogenesis.
Cano CE; Hamidi T; Garcia MN; Grasso D; Loncle C; Garcia S; Calvo E; Lomberk G; Dusetti N; Bartholin L; Urrutia R; Iovanna JL
Gut; 2014 Jun; 63(6):984-95. PubMed ID: 24026351
[TBL] [Abstract][Full Text] [Related]
15. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients.
Lim SA; Kim J; Jeon S; Shin MH; Kwon J; Kim TJ; Im K; Han Y; Kwon W; Kim SW; Yee C; Kim SJ; Jang JY; Lee KM
Front Immunol; 2019; 10():496. PubMed ID: 31024520
[TBL] [Abstract][Full Text] [Related]
16. NK cells in pancreatic cancer demonstrate impaired cytotoxicity and a regulatory IL-10 phenotype.
Marcon F; Zuo J; Pearce H; Nicol S; Margielewska-Davies S; Farhat M; Mahon B; Middleton G; Brown R; Roberts KJ; Moss P
Oncoimmunology; 2020 Nov; 9(1):1845424. PubMed ID: 33299656
[TBL] [Abstract][Full Text] [Related]
17. A novel refined pyroptosis and inflammasome-related genes signature for predicting prognosis and immune microenvironment in pancreatic ductal adenocarcinoma.
Zuo J; Yi C; Chen Z; Zhou B; Yang T; Lin J
Sci Rep; 2022 Nov; 12(1):18384. PubMed ID: 36319832
[TBL] [Abstract][Full Text] [Related]
18. Prognostic-Related Biomarkers in Pancreatic Ductal Adenocarcinoma Correlating with Immune Infiltrates Based on Proteomics.
Kou YQ; Yang YP; Pan ZJ; Du SS; Yuan WN; He K; Nie B
Med Sci Monit; 2023 Mar; 29():e938785. PubMed ID: 36905103
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice.
Huang C; Li Z; Li N; Li Y; Chang A; Zhao T; Wang X; Wang H; Gao S; Yang S; Hao J; Ren H
Gastroenterology; 2018 Feb; 154(3):675-688. PubMed ID: 28989066
[TBL] [Abstract][Full Text] [Related]
20. Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions.
Lin W; Noel P; Borazanci EH; Lee J; Amini A; Han IW; Heo JS; Jameson GS; Fraser C; Steinbach M; Woo Y; Fong Y; Cridebring D; Von Hoff DD; Park JO; Han H
Genome Med; 2020 Sep; 12(1):80. PubMed ID: 32988401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]